Verano Holdings (VRNO) Current Assets (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Current Assets of $394.5 million for Q1 2026, up 9.24% year-over-year from $361.1 million in Q1 2025, and down 2.5% quarter-over-quarter from $404.7 million in Q4 2025.
Verano Holdings (VRNO) Current Assets (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Current Assets for 6 consecutive years, with $394.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 9.24% year-over-year to $394.5 million; the TTM figure through Mar 2026 stood at $394.5 million (up 9.24% YoY), while the FY2025 annual figure was $404.7 million, up 11.58% from the prior year.
- Current Assets fell to $394.5 million in Q1 2026 per VRNO's latest filing, from $404.7 million in the prior quarter.
- Across five years, Current Assets topped out at $418.8 million in Q1 2024 and bottomed at $288.0 million in Q2 2022.
- Historically, Current Assets has averaged $353.9 million across 5 years, with a median of $359.4 million in 2024.
- Annual changes were most pronounced in 2024 — Current Assets jumped 32.63% — and 2025, when it decreased 13.76%.
- Verano Holdings' Current Assets stood at $318.3 million in 2022, then gained by 23.85% to $394.2 million in 2023, then decreased by 8.0% to $362.7 million in 2024, then increased by 11.58% to $404.7 million in 2025, then dropped by 2.5% to $394.5 million in 2026.
- Business Quant data shows VRNO's Current Assets at $394.5 million in Q1 2026, $404.7 million in Q4 2025, and $385.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.22 Bn |
| 10 | Verano Holdings | 441.74 Mn | 356.55 Mn | 99.70 Mn | 404.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 404.28 Mn |
| Mar 31, 2026 | 394.52 Mn |
| Dec 31, 2025 | 404.65 Mn |
| Sep 30, 2025 | 385.43 Mn |
| Jun 30, 2025 | 371.36 Mn |
| Mar 31, 2025 | 361.14 Mn |
| Dec 31, 2024 | 362.65 Mn |
| Sep 30, 2024 | 321.72 Mn |
| Jun 30, 2024 | 357.56 Mn |
| Mar 31, 2024 | 418.78 Mn |
| Dec 31, 2023 | 394.20 Mn |
| Sep 30, 2023 | 355.00 Mn |
| Jun 30, 2023 | 318.93 Mn |
| Mar 31, 2023 | 315.76 Mn |
| Dec 31, 2022 | 318.28 Mn |
| Sep 30, 2022 | 295.07 Mn |
| Jun 30, 2022 | 287.96 Mn |
| Dec 31, 2021 | 277.04 Mn |